Ameliorative Potentials of <i>Vernonia amygdalina</i> in High-fat Diet and Letrozole-induced Polycystic Ovary Syndrome in Female Wistar Rats

Authors

  • Great O. Adebodun Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria.
  • Abigail Dikne Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria.
  • Akachi Egbeke Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria.
  • Habibah Arikawe Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria.
  • Bonnke Bello Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria.
  • Kelechi Ekwobi Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria.
  • Abimbola O. Ogunsola Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Ogun State, Nigeria.

DOI:

https://doi.org/10.26538/tjnpr/v8i4.34%20

Keywords:

antioxidants, insulin, letrozole, Vernonia amygdalina, Polycystic ovary syndrome

Abstract

Polycystic ovary syndrome (PCOS) is a metabolic and reproductive disorder that disrupts the female reproductive cycle, resulting in infertility. There is a need for safer and more effective options for managing this disorder. Therefore, this study explored the effects of Vernonia amygdalina (VA) extract administration on insulin levels, inflammation markers, oxidative stress, and reproductive hormones in PCOS rats. Twenty-five female Wistar rats were randomly divided into 5 groups (n = 5) namely: PCOS untreated, normal control, treatment groups (400 mg/kg and 200 mg/kg of VA extract, respectively), and standard group (metformin and clomiphene citrate). PCOS was induced with 1 mg/kg letrozole coupled with a high-fat diet for 28 days. The treatment groups were orally administered with VA extract for 2 weeks. Blood samples were obtained for insulin, oxidative stress markers, lipid profile, inflammatory markers, and reproductive hormone level analysis, and data were analyzed. Extracts of VA significantly reduced insulin and luteinizing hormone levels; increased follicle-stimulating hormone and progesterone levels in comparison with the PCOS untreated group. Serum IL-6, CRP, and TNF-α levels were lower in the treatment groups compared to the PCOS untreated group. A significant reduction in malondialdehyde level was observed, with no significant difference in catalase and superoxide dismutase levels in comparison to the PCOS untreated group. Groups administered VA had significant reductions in triglycerides and LDL-C levels, while HDL-C levels was significantly increased in comparison to the PCOS untreated group. Extracts of Vernonia amygdalina could be therapeutic in PCOS management.

References

Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr. Rev. 2016; 37(5): 467-520.

Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin. Chim. Acta. 2020; 502: 214-21.

McCartney CR, Marshall JC. Polycystic ovary syndrome. N. Engl. J. Med. 2016; 375(1): 54-64.

Abtahi-Eivari SH, Moghimian M, Soltani M, Shoorei H, Asghari R, Hajizadeh H, Shokoohi M, Alami S, Ghaderi FK. The effect of Galega officinalis on hormonal and metabolic profile in a rat model of polycystic ovary syndrome. Int. J. Women's Health Reprod. 2018; 6(3): 276-82.

Ilhan M, Ali Z, Khan IA, Tastan H, Küpeli Akkol E. Isolation and identification of triterpenes from Anthemis austriaca Jacq. through bioactivity-guided fractionation on polycystic ovary syndrome rat model. Arch. Gynecol. Obstet. 2020; 1(4): 1103-11.

Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol. Metab. 2020; 35: 100937.

Moghetti P, Tosi F. Insulin resistance and PCOS: chicken or egg? J. Endocrinol. 2021; 44: 233-44.

Younas A, Hussain L, Shabbir A, Asif M, Hussain M, Manzoor F. Effects of Fagonia indica on Letrozole-Induced Polycystic Ovarian Syndrome (PCOS) in Young Adult Female Rats. Evid. Based Complementary Altern. Med. 2022; 1397060.

Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, Pugeat MM, Rosenfield RL. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. 2018; 103(4): 1233-57.

Parikha PS, Krishna A. Anti-hyperglycaemic activity of tribulus terrestris fruit extract restores metabolic imbalance in letrozole induced-PCOS mice. Int. J. Pharmacogn. Phytochem. 2019; 11(4): 304-11.

Alqahtani AS, Ullah R, Shahat AA. Bioactive constituents and toxicological evaluation of selected antidiabetic medicinal plants of Saudi Arabia. Evid. Based Complementary Altern. Med. 2022; 7123521.

Nwosu SI, Stanley HO, Okerentugba PO. Occurrence, types and location of calcium oxalate crystals in Vernonia amydalina Del (Asteraceae). Int. J. Sci. Nat. 2013; 4(3): 533-7.

IfedibaluChukwu EI, Aparoop D, Kamaruz Z. Antidiabetic, anthelmintic and antioxidation properties of novel and new phytocompounds isolated from the methanolic stem-bark of Vernonia amygdalina Delile (Asteraceae). Sci. African. 2020; 10: e00578.

Oyeyemi IT, Akinlabi AA, Adewumi A, Aleshinloye AO, Oyeyemi OT. Vernonia amygdalina: A folkloric herb with anthelminthic properties. Beni-Suef Univ. J. Basic Appl. Sci. 2018; 7(1): 43-9.

Oladele JO, Oyeleke OM, Oladele OT, Olaniyan M. Neuroprotective mechanism of Vernonia amygdalina in a rat model of neurodegenerative diseases. Toxicol. 2020; 7: 1223-32.

Ugbogu EA, Emmanuel O, Dike ED, Agi GO, Ugbogu OC, Ibe C, Iweala EJ. The phytochemistry, ethnobotanical, and pharmacological potentials of the medicinal plant-Vernonia amygdalina L.(bitter Leaf). Clin. Complem. Med. Pharm. 2021; 1(1): 100006.

Ogunlakin AD, Sonibare MA. Ethnobotanical survey of medicinal plants used as remedy for female infertility and menstrual disorder in southwestern Nigeria. Niger. J. Pharm. 2019; 15(2): 205-17.

Wang MX, Yin Q, Xu X. A rat model of polycystic ovary syndrome with insulin resistance induced by letrozole combined with high fat diet. Medical Science Monitor: Int. Med. J. Exp. Clin. 2020; 26: e922136-1.

Kausar F, Rather MA, Bashir SM, Alsaffar RM, Nabi SU, Ali SI, Goswami P, Ahmad A, Rashid S, Wali AF. Ameliorative effects of Cuscuta reflexa and Peucedanum grande on letrozole induced polycystic ovary syndrome in Wistar rats. Redox Rep. 2021; 26(1): 94-104.

Loh K, Tam S, Murray‐Segal L, Huynh K, Meikle PJ, Scott JW, van Denderen B, Chen Z, Steel R, LeBlond ND, Burkovsky, LA. Inhibition of Adenosine Monophosphate–Activated Protein Kinase–3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin Resistance. Hepatol. Commun. 2019; 3(1): 84-98.

Kaur D, Kaur N, Chopra A. A comprehensive review on phytochemistry and pharmacological activities of Vernonia amygdalina. J. Pharm. Phytochem. 2019; 8: 2629-36.

Ogidi OI, George DG, Esie NG. Ethnopharmacological properties of Vernonia amygdalina (Bitter Leave) medicinal plant. J. Medicinal Plants. 2019; 7(2): 175-81.

Olamoyegun MA, Omisore NO, Yusuf AO, Odewale TE. Assessment of Pharmacodynamic Interactions and Toxicological Effects of Vernonia amygydalina-Metformin Co-Administration on Streptozotocin-Induced Diabetic Wistar Rats. Trop J Nat Prod Res. 2022; 6(12): 2073-2080.

Ndeingang EC, Defo Deeh PB, Watcho P, Kamanyi A. Phyllanthus muellerianus (Euphorbiaceae) restores ovarian functions in letrozole-induced polycystic ovarian

syndrome in rats. Evid. Based Complementary Altern. Med. 2019; 2965821.

Reddy PS, Begum N, Mutha S, Bakshi V. Beneficial effect of Curcumin in Letrozole induced polycystic ovary syndrome. Asian Pac J Reprod. 2016; 5(2): 116-22.

Pourteymour Fard Tabrizi F, Hajizadeh-Sharafabad F, Vaezi M, Jafari-Vayghan H, Alizadeh M, Maleki V. Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review. J. Ovarian Res. 2020; 13(1): 1-0.

Papalou OM, Victor V, Diamanti-Kandarakis E. Oxidative stress in polycystic ovary syndrome. Curr. Pharm. Des. 2016; 22(18): 2709-2722.

Adesanoye OA, Farombi EO. In vitro Antioxidant Properties of methanolic leaf extract of Vernonia amygdalina Del. Niger. J. Physiol. Sci. 2014; 29(2): 93-101.

Adewole E, Ojo A, Ogunmodede OT, Adewumi DF. Antioxidant activities and nutritional compositions of Vernonia amygdalina. Int. J. Basic Appl. Sci. 2015; 4(01): 9-16.

Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What's new?. Adv Clin Exp Med. 2017; 26(2): 359-367.

Pachiappan S, Ramalingam K, Balasubramanian A. Combined effects of Gymnema sylvestre and Pergularia daemia on letrozole-induced polycystic ovarian syndrome in rats. Asian Pac J Reprod. 2021; 10(2): 68-74.

Ogunlakin AD, Sonibare MA. Antioxidant and Ameliorative Effects of Basella alba L. On Letrozole-Induced Polycystic Ovarian Syndrome in Rats. Trop J Nat Prod Res. 2023; 7(4): 2817-2822.

Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J. Psychol. Med. 2018; 40(3): 239-246.

Pyun BJ, Yang H, Sohn E, Yu SY, Lee D, Jung DH, Ko BS, Lee HW. Tetragonia tetragonioides (Pall.) kuntze regulates androgen production in a letrozole-induced polycystic ovary syndrome model. Molecules. 2018; 23(5): 1173.

Oladele JO, Oyeleke OM, Oladele OT, Babatope OD, Awosanya OO. Nitrobenzene-induced hormonal disruption, alteration of steroidogenic pathway, and oxidative damage in rat: protective effects of Vernonia amygdalina. Clin. Phytoscience. 2020; 6: 1-9.

Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HE, Amer S. The role of chronic inflammation in polycystic ovarian syndrome—a systematic review and meta-analysis. Int. J. Mol. Sci. 2021; 22(5): 2734.

Quasie O, Zhang YM, Zhang HJ, Luo J, Kong LY. Four new steroid saponins with highly oxidized side chains from the leaves of Vernonia amygdalina. Phytochem Lett. 2016; 15: 16-20.

Robertson DM. Inhibins and activins in blood: predictors of female reproductive health?. Mol. Cell. Endocrinol.. 2012; 359(1-2):78-84.

Downloads

Published

2024-05-01

How to Cite

Adebodun, G. O., Dikne, A., Egbeke, A., Arikawe, H., Bello, B., Ekwobi, K., & Ogunsola, A. O. (2024). Ameliorative Potentials of <i>Vernonia amygdalina</i> in High-fat Diet and Letrozole-induced Polycystic Ovary Syndrome in Female Wistar Rats. Tropical Journal of Natural Product Research (TJNPR), 8(4), 6995–6999. https://doi.org/10.26538/tjnpr/v8i4.34